BackNanobiotix S.A. Overview

Nanobiotix S.A. Total Liabilities

Latest total liabilities for NNBXF: $160M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$161.65M
↑ 41.64% YoYΔ $47.52M vs prior year quarter

Peer trimmed avg / median

Loading

Nanobiotix S.A. Total Liabilities History

Loading

Nanobiotix S.A. vs. peers: Total Liabilities Comparison

Loading

Nanobiotix S.A. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Nanobiotix S.A. (NNBXF) FAQ

As of the most recent data (June 2026), NNBXF shows a total liabilities of $160M. That compares with $110M in the prior-year period — up 41.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NNBXF's total liabilities is now $160M (was $110M) — a 41.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Nanobiotix S.A. is outperforming or lagging.

Tracking NNBXF's total liabilities over time shows whether Nanobiotix S.A. is scaling, shrinking, or reshaping that part of the business. The current reading is $160M That compares with $110M in the prior-year period — up 41.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Nanobiotix S.A.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $160M) with ownership activity and broader fundamentals.

Nanobiotix S.A.'s total liabilities is $160M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.

Questions & Answers